Pomerantz LLP Investigating TechTarget Securities Fraud Claims
ByAinvest
Tuesday, Apr 29, 2025 10:47 am ET1min read
TTGT--
On March 31, 2025, TechTarget disclosed that it would be unable to meet the deadline for filing its 2024 Annual Report. The company attributed this delay to the need for further evaluation of technical accounting matters related to its combination with the "Informa Tech Digital Businesses" [2]. Additionally, TechTarget revealed that it expects to record a pre-tax non-cash goodwill impairment charge related to the business in the range of approximately $70 million to $110 million for the 2024 fiscal year.
Following these disclosures, TechTarget's stock price experienced a significant decline. On April 1, 2025, the stock closed at $12.76 per share, a 12.75% decrease from its previous closing price of $14.81 per share on March 31, 2025 [2].
Investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980 for further information about the investigation.
References:
[1] https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-adverum-biotechnologies-inc---advm-302440201.html
[2] https://www.tradingview.com/news/reuters.com,2025-04-29:newsml_GNX7KgHXc:0-bragar-eagel-squire-p-c-is-investigating-techtarget-and-aldeyra-and-encourages-investors-to-contact-the-firm/
Pomerantz LLP is investigating claims of securities fraud against TechTarget, Inc. (NASDAQ: TTGT) and its officers and directors. The investigation concerns TechTarget's failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2024. As a result, TechTarget's stock price fell 12.75% to $7.12 per share on April 21, 2025. Investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980 for further information.
Pomerantz LLP, a prominent law firm specializing in corporate and securities litigation, has initiated an investigation into potential claims of securities fraud against TechTarget, Inc. (NASDAQ: TTGT) and its officers and directors. The investigation centers on TechTarget's failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2024.On March 31, 2025, TechTarget disclosed that it would be unable to meet the deadline for filing its 2024 Annual Report. The company attributed this delay to the need for further evaluation of technical accounting matters related to its combination with the "Informa Tech Digital Businesses" [2]. Additionally, TechTarget revealed that it expects to record a pre-tax non-cash goodwill impairment charge related to the business in the range of approximately $70 million to $110 million for the 2024 fiscal year.
Following these disclosures, TechTarget's stock price experienced a significant decline. On April 1, 2025, the stock closed at $12.76 per share, a 12.75% decrease from its previous closing price of $14.81 per share on March 31, 2025 [2].
Investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980 for further information about the investigation.
References:
[1] https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-adverum-biotechnologies-inc---advm-302440201.html
[2] https://www.tradingview.com/news/reuters.com,2025-04-29:newsml_GNX7KgHXc:0-bragar-eagel-squire-p-c-is-investigating-techtarget-and-aldeyra-and-encourages-investors-to-contact-the-firm/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet